Clinical Trials Browser

Phase 2 × sapacitabine × Other hematologic neoplasm × Clear all

NCT00590187 2024-06-04

Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients

Phase 2 Completed

105 enrolled 11 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01253460 2019-09-06

Sapacitabine, Cyclophosphamide, Rituximab for Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (CLL/SLL) With Deletion (11q22-23)

Phase 2 Terminated

18 enrolled 10 charts

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell